1313513-41-5

Basic information

• Product Name: methyl 2-bromo-4-(bromomethyl)-5-chlorobenzoate
• Synonyms: methyl 2-bromo-4-(bromomethyl)-5-chlorobenzoate
• CAS NO: 1313513-41-5
• Molecular Weight: 342.414
• Mol File: 1313513-41-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: methyl 2-bromo-4-(bromomethyl)-5-chlorobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-bromo-4-(bromomethyl)-5-chlorobenzoate(1313513-41-5)
• EPA Substance Registry System: methyl 2-bromo-4-(bromomethyl)-5-chlorobenzoate(1313513-41-5)

Safety Data

• Hazardous Substances Data: 1313513-41-5(Hazardous Substances Data)

Upstream product

• 1426923-27-4 C₈H₆BrClO₂ 
• 7697-27-0 2-bromo-4-methylbenzoic acid 
• 474330-54-6 5-amino-2-bromo-4-methylbenzoic acid methyl ester 
• 745048-63-9 5-amino-2-bromo-4-methylbenzoic acid 
• 2458-12-0 3-amino-p-toluic acid 
• 1061314-02-0 2-bromo-5-chloro-4-methyl-benzoic acid methyl ester 

Downstream Products

• 1313513-39-1 2-bromo-5-chloro-4-(hydroxymethyl)benzoic acid 
• 1313513-45-9 C₁₇H₂₆BrClO₃Si 
• 1313513-46-0 (2-bromo-5-chloro-4-((triisopropylsilyloxy)methyl)phenyl)methanol 
• 1313513-44-8 (4-(allyloxymethyl)-5-bromo-2-chlorobenzyloxy)triisopropylsilane 
• 1313513-47-1 2-(4-(allyloxymethyl)-2-chloro-5-((2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)acetic acid 
• 1313513-48-2 2-(4-(allyloxymethyl)-2-chloro-5-((2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)-tetrahydro-2H-pyran-2-yl)benzyl)-5-(furan-2-yl)thiazole 
• 1313513-49-3 (2S,3R,4R,5S,6R)-2-(4-chloro-5-((5-(furan-2-yl)thiazol-2-yl)methyl)-2-(hydroxymethyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-53-9 (2S,3R,4R,5S,6R)-2-(2-(allyloxymethyl)-4-chloro-5-((5-(furan-2-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-50-6 (2S,3R,4R,5S,6R)-2-(4-chloro-5-((5-(furan-3-yl)thiazol-2-yl)methyl)-2-(hydroxymethyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-54-0 (2S,3R,4R,5S,6R)-2-(2-(allyloxymethyl)-4-chloro-5-((5-(furan-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-51-7 (2S,3R,4R,5S,6R)-2-(4-chloro-2-(hydroxymethyl)-5-((5-(thiophen-2-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-55-1 (2S,3R,4R,5S,6R)-2-(2-(allyloxymethyl)-4-chloro-5-((5-(thiophen-2-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-52-8 (2S,3R,4R,5S,6R)-2-(4-chloro-2-(hydroxymethyl)-5-((5-(thiophen-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1313513-56-2 (2S,3R,4R,5S,6R)-2-(2-(allyloxymethyl)-4-chloro-5-((5-(thiophen-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 

Relevant articles and documents

2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS

The present invention relates to Nav1.8 Inhibitor 2,3-dihydroquinazolin compounds of Formula (X); wherein Y', X', B', R1', R2', R3', R5', R6', R7', and z1 are as defined herein; or pharmaceutically acceptable salts or tautomer forms thereof, corresponding pharmaceutical compositions or formulations, methods or processes of compound preparation, methods, compounds for use in, uses for and/or combination therapies for treating pain and/or pain-related or associated disease(s), disorder(s) or condition(s), respectively.

THIAZOLE DERIVATIVES AS SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

The present invention relates to a novel compound with thiazole ring having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes.